TMCnet News
Molecular Diagnostics Reports Bundle Featuring Reports on Cancer testing, Genetic testing, Infectious Disease Testing & MD Markets - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/lpx4kv/molecular) has announced the addition of the "Molecular Diagnostics Reports Bundle" report to their offering. The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately: - Molecular Diagnostics in Cancer Testing - Molecular Diagnostics in Genetic Testing - Molecular Diagnostics in Infectious Disease Testing - Molecular Diagnostics Markets Below are summaries of each report as well as links to purchase the individual titles. 'Molecular Diagnostics in Cancer Testing' (2015) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. 'Molecular Diagnostics in Genetic Testing' (2013) Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. The confluence of breakthroughs in genomics and proteomics and the development of microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. Major dvelopments include the integration of specialty labs and gene expression profiling into clinical practice, the introduction and rapid growth of cell-free fetal DNA prenatal testing, the advancement of companion diagnostics for drug development, the widespread installed base of automated instruments for molecular testing and the development of personalized medicine. 'Molecular Diagnostics in Infectious Disease Testing' (2015) This report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in the blood--has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. 'Molecular Diagnostics Markets' (2013) The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels--are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor's offices. Companies Mentioned - Sample List of the 100+ Companies Featured - ARCA biopharma - Abbott Laboratories - Adnavance Technologies, Inc. - AdvanDx - Agendia - BG Medicine - Beckman Coulter - Becton, Dickinson and Company - bioMerieux - bioTheranostics - Bio-Rad Laboratories - BioGenex Laboratories, Inc - BioHelix Corporation - Gene Express - GeneOhm Sciences - Genera Biosystems - Genmark Diagnostics, Inc - Genomic Health, Inc. - Genomica - Genomix Biotech - Genoptix, Inc. - Genzyme Corporation - Great Basin Scientific - Hologic, Inc - Illumina, Inc - Nanogen - Nanosphere - Natera - NetBio - NorDiag ASA - U.S. Genomics, Inc. - Veredus Laboratories - Veridex - Xenomics, Inc. For more information visit http://www.researchandmarkets.com/research/lpx4kv/molecular
View source version on businesswire.com: http://www.businesswire.com/news/home/20160208005703/en/ |
